Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

FY19 Result – Why The NIB (ASX:NHF) Share Price Is On Watch

The NIB Holdings Limited (ASX:NHF) share price will be on watch today after reporting its FY19 result. 

The NIB Holdings Limited (ASX: NHF) share price will be on watch today after reporting its FY19 result.

NIB is one of the ASX’s largest private health insurers, it was founded in 1952. NIB provides health and medical insurance to over 1.5 million Australian and New Zealand residents. NIB also provide health insurance to more than 160,000 international students and workers in Australia. It’s also Australia’s third largest travel insurer and global distributor of travel insurance through its World Nomads Group business.

NIB’s Healthy FY19 Report

The private health insurer reported that its group underlying revenue rose by 8.3% to $2.4 billion. Meanwhile, the group claims expense (excluding travel claims) only increased by 6.9% to $1.8 billion.

NIB revealed that it achieved net policyholder growth of 2.1% for the year, which although low, would likely be fairly impressive growth compared to the rest of the private health insurance industry.

Whilst the company continues to diversify its operations and earnings, its Australian resident health insurance business still accounts for almost 75% of group operating profit.

Group underlying operating profit (UOP) grew by 9.2% to $201.8 million and net profit after tax grew by 11.8% to $149.3 million.

The ‘other’ businesses made a combined underlying operating profit of $61.3 million. The international students and workers business grew net policyholders by almost 20%, UOP grew by 17.9% to $34.9 million.

However, both the New Zealand and travel business saw small declines.

NIB Management Comments

NIB CEO and Managing Director Mark Fitzgibbon said: “Market conditions have been challenging for a range of reasons. There’s broad weakness in consumer discretionary spending, fierce competition for that spending and private health insurance has some issues around cost and affordability, especially out of pocket expenses for members.”

NIB Dividend

The NIB Board decided to pay a final dividend of 13 cents per share, bringing the full year dividend to 23 cents – an increase of 15%.

Is NIB A Buy?

NIB is expecting to make a group UOP of at least $200 million in FY20, including the likelihood of higher claims inflation and lower Australian resident health insurance margins.

This result would mean profit would be at least flat compared to FY19, which is not a bad result all things considering. But, I’m wary of investing until there’s a solution to the problem of high costs of the insurance causing young people leaving and rising costs from an ageing population.

I think the below growth shares in the free report below could be a better idea for the long term.

[ls_content_block id=”14947″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content